Picture of ProMIS Neurosciences logo

PMN — ProMIS Neurosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

ProMIS Neurosciences Inc expected to post a loss of 14 cents a share - Earnings Preview

ProMIS Neurosciences Inc PMN.OQ PMN.O is expected to show no change in quarterly revenue when it reports  results on March 31 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for ProMIS Neurosciences Inc is for a loss of 14 cents per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for ProMIS Neurosciences Inc is $8.00​, above​ its last closing price of $0.70. ​​​

This summary was machine generated March 28 at 21:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on ProMIS Neurosciences

See all news